Table 2 Analysis of risk factors for nasal and throat colonization of MRSA in HIV positive individuals attending HIV care service in Northern Ethiopia, September 2014–February 2015
Variables | Frequency (%) | MRSA colonization |
|---|---|---|
No. (%) | ||
Age in years | ||
1–9R | 10 (4.0) | 0 (0) |
10–19 | 19 (7.6) | 0 (0) |
20–29 | 35 (14.1) | 2 (5.7) |
30–39 | 103 (41.4) | 3 (2.9) |
40–49 | 55 (22.1) | 1 (1.8) |
50–59 | 17 (6.8) | 0 (0) |
60–69 | 7 (2.8) | 0 (0) |
70–79 | 3 (1.2) | 0 (0) |
Sex | ||
Female | 174 (69.9) | 6 (3.4) |
Male | 75 (30.1) | 0 (0) |
Hospitalization in the past 6 months | ||
No | 223 (89.6) | 4 (1.8) |
Yes | 26 (10.4) | 2 (7.7) |
Hospital visit in the past 12 months | ||
No | 61 (24.5) | 2 (3.3) |
Yes | 188 (75.5) | 4 (2.1) |
Household member hospitalization in the past 1 year | ||
No | 224 (90) | 4 (1.8) |
Yes | 25 (10) | 2 (8.0) |
Presence of percutaneous device in the past 1 year | ||
No | 189 (75.9) | 2 (1.1) |
Yes | 60 (24.1) | 4 (6.7) |
Oral antibiotic usage in the past 3 months | ||
No | 181 (72.7) | 3 (1.7) |
Yes | 68 (27.3) | 3 (4.4) |
Current use of trimethoprim-sulfamethoxazole | ||
No | 161 (64.7) | 2 (2.3) |
Yes | 88 (35.3) | 4 (2.5) |
Most recent CD4 count | ||
<200 | 37 (14.9) | 3 (8.1) |
200–500 | 109 (43.8) | 1 (0.9) |
>500 | 103 (41.4) | 2 (1.9) |